Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 4
1954 6
1955 12
1956 4
1957 3
1959 2
1960 8
1961 6
1962 7
1963 2
1964 3
1965 4
1966 1
1967 12
1968 5
1969 6
1970 6
1971 1
1972 1
1973 1
1976 1
1977 5
1978 4
1979 2
1980 2
1981 1
1983 2
1984 2
1985 1
1986 2
1987 2
1988 6
1989 7
1990 5
1991 1
1992 2
1993 1
1994 3
1995 4
1996 6
1997 3
1998 5
1999 1
2000 2
2001 3
2002 2
2003 2
2004 2
2005 10
2006 8
2007 9
2008 4
2009 3
2010 4
2011 5
2012 13
2013 9
2014 9
2015 9
2016 15
2017 15
2018 8
2019 10
2020 13
2021 8
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

311 results
Results by year
Filters applied: . Clear all
Page 1
Crizotinib-induced immunogenic cell death in non-small cell lung cancer.
Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, Martin T, Xia L, Yang H, Li Q, Chen J, Durand S, Aprahamian F, Lefevre D, Broutin S, Paci A, Bongers A, Minard-Colin V, Tartour E, Zitvogel L, Apetoh L, Ma Y, Pittet MJ, Kepp O, Kroemer G. Liu P, et al. Among authors: paci a. Nat Commun. 2019 Apr 2;10(1):1486. doi: 10.1038/s41467-019-09415-3. Nat Commun. 2019. PMID: 30940805 Free PMC article.
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.
Coutzac C, Jouniaux JM, Paci A, Schmidt J, Mallardo D, Seck A, Asvatourian V, Cassard L, Saulnier P, Lacroix L, Woerther PL, Vozy A, Naigeon M, Nebot-Bral L, Desbois M, Simeone E, Mateus C, Boselli L, Grivel J, Soularue E, Lepage P, Carbonnel F, Ascierto PA, Robert C, Chaput N. Coutzac C, et al. Among authors: paci a. Nat Commun. 2020 May 1;11(1):2168. doi: 10.1038/s41467-020-16079-x. Nat Commun. 2020. PMID: 32358520 Free PMC article.
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.
Yen K, Travins J, Wang F, David MD, Artin E, Straley K, Padyana A, Gross S, DeLaBarre B, Tobin E, Chen Y, Nagaraja R, Choe S, Jin L, Konteatis Z, Cianchetta G, Saunders JO, Salituro FG, Quivoron C, Opolon P, Bawa O, Saada V, Paci A, Broutin S, Bernard OA, de Botton S, Marteyn BS, Pilichowska M, Xu Y, Fang C, Jiang F, Wei W, Jin S, Silverman L, Liu W, Yang H, Dang L, Dorsch M, Penard-Lacronique V, Biller SA, Su SM. Yen K, et al. Among authors: paci a. Cancer Discov. 2017 May;7(5):478-493. doi: 10.1158/2159-8290.CD-16-1034. Epub 2017 Feb 13. Cancer Discov. 2017. PMID: 28193778 Free article.
Prodrugs as drug delivery system in oncology.
Delahousse J, Skarbek C, Paci A. Delahousse J, et al. Among authors: paci a. Cancer Chemother Pharmacol. 2019 Nov;84(5):937-958. doi: 10.1007/s00280-019-03906-2. Epub 2019 Aug 7. Cancer Chemother Pharmacol. 2019. PMID: 31392391 Review.
Late phase 1 studies: concepts and outcomes.
Benitez JC, Geraud A, Texier M, Massard C, Paci A, Soria JC, Besse B. Benitez JC, et al. Among authors: paci a. Lancet Oncol. 2021 Oct;22(10):e446-e455. doi: 10.1016/S1470-2045(21)00467-8. Lancet Oncol. 2021. PMID: 34592194 Review.
311 results